Wilmar-Renuka Sugars Deal Gets Competition Regulator Nod
Fair trade watchdog CCI has cleared Singapore-based Wilmar Sugar Holdings proposed plan to purchase shares in Renuka Sugars, saying the deal will not have an adverse impact on competition in the country.
Under the proposed deal, Wilmar would acquire shares of Renuka Sugars, a domestic firm, pursuant to a preferential allotment and a consequential open offer to the shareholders.
In an order released today, the Competition Commission of India (CCI) said, "The proposed combination is not likely to have an appreciable adverse effect on competition in India".
The watchdog observed that Wilmar had no presence in India in the business of refining of raw sugar, production of sugar and ethanol derived from sugarcane and generation of electricity/power from bagasse.
It also stated that Wilmar had relatively insignificant exports and imports of sugar from/to India during the
preceding financial year.
"In view of the foregoing and considering the presence of a large number of organised and unorganised players in sugar industry in India, the proposed combination is not likely to give rise to any competition concern in India," it added.
As per the deal, Wilmar would be required to make an open offer to the public shareholders of Renuka Sugars to acquire up to 26 per cent of the company.
In terms of the open offer, Wilmar and Singapore-based SRS Investments would acquire the shares tendered in the open offer as agreed between them, the order said.
Renuka Sugars is engaged in the business of refining of raw sugar, production of sugar and ethanol derived from sugarcane, among others.
Wilmar is part of the Wilmar International Ltd group that has various business interests such as in oil palm
cultivation, oilseeds crushing, sugar milling and refining.
The companies had entered into agreements on February 20 following which they had filed a notice seeking the Commission's approval on March 11.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.